Fibrin sealant patch cleared for use in liver surgery



The Food and Drug Administration has expanded the indication of Evarrest (fibrin sealant) to include use as an adjunct to hemostasis for control of bleeding during adult liver surgery.

The drug also has been indicated for use with manual compression as an adjunct to hemostasis for soft-tissue bleeding during open retroperitoneal, intra-abdominal, pelvic, and noncardiac thoracic surgery. Evarrest has not yet been approved for pediatric use.

Evarrest is made by Ethicon Biosurgery, a division of Ethicon.

Next Article:

   Comments ()